Delivery Order SPE2DR25D9239-SPE2DR26FFCS2
Award Date 4/16/26
Potential Completion Date 5/7/26
Potential Value $7.2K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a $11,762.24 delivery order to DMS Pharmaceutical Group Inc. on March 11, 2026, for VABYSMO 6 mg/0.05 mL syringes under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract supporting the supply of branded and generic pharmaceuticals, biologics, and medical consumables to Department of Defense military healthcare facilities worldwide. The parent IDC, awarded to DMS...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on March 16, 2026, with a ceiling value of $8,821.68 for VABYSMO 6 mg/0.05 mL syringes. The order is issued under the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a single-award indefinite delivery contract with a $499.999 billion ceiling authorizing DLA to issue firm fixed-price delivery orders for pharmaceutical products and medical consumables to support...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 23, 2026, with a ceiling value of $22,054.20 for supply of VABYSMO 6 MG/0.05 ML syringes under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract for pharmaceutical products and medical consumables supporting Department of Defense healthcare operations worldwide. Place of performance is Park Ridge,...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 6, 2026, for Vabysmo 6 mg/0.05 mL syringes, with a ceiling value of $14,702.80, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). The PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables to...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on March 23, 2026, for VABYSMO 6 mg/0.05 mL syringes, with a ceiling value of $22,054.20. The order is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a Defense Logistics Agency indefinite delivery contract that authorizes firm fixed-price delivery orders for pharmaceutical products and medical consumables to support Department of Defense healthcare operations globally....
- The Defense Logistics Agency issued a $5,881.12 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, on February 11, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for VABYSMO 6 MG/0.05 ML syringes. PPV-G GEN V is the Defense Logistics Agency's indefinite delivery contract authorizing firm fixed-price orders for pharmaceutical products and medical consumables to support Department of Defense military healthcare facilities...
- The Defense Logistics Agency issued a $1,197.85 delivery order to DMS Pharmaceutical Group Inc. on March 12, 2026, for VABYSMO 6MG/0.05ML pharmaceutical product under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). DMS Pharmaceutical Group is a woman-owned small business pharmaceutical wholesaler. The order is placed under the PPV-G GEN V indefinite delivery contract, a Defense Logistics Agency pharmaceutical prime vendor program authorizing firm fixed-price delivery...
- The Defense Logistics Agency issued a $5,881.12 delivery order to DMS Pharmaceutical Group Inc. on March 17, 2026, for Vabysmo 6 mg/0.05 ml syringes under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is the Defense Logistics Agency's indefinite delivery contract for pharmaceutical products including branded and generic prescription drugs, biologics, and medical consumables to support Department of Defense healthcare operations globally. DMS...
- The Defense Logistics Agency issued a $17,866.52 delivery order to DMS Pharmaceutical Group Inc. on March 3, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical products to support Department of Defense healthcare operations. PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract with a $499,999,999 ceiling and a December 31, 2036 ultimate completion date. DMS Pharmaceutical Group is a woman-owned small business...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on March 3, 2026, for VABYSMO 6 mg/0.05 mL syringes, with a ceiling value of $8,821.68 and an ultimate completion date of March 24, 2026. DMS Pharmaceutical Group is a woman-owned small business pharmaceutical wholesaler. The order is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a Defense Logistics Agency indefinite delivery contract that provides firm fixed-price...